Home >
News >
#ESHERYTHRO2025 THE LEARNING OBJECTIVES
#ESHERYTHRO2025 THE LEARNING OBJECTIVES
September 19, 2024
4th Translational Research Conference
Pathophysiology and Clinical Advances
in Sickle Cell Disease and Thalassemia
Save the date: March 14-16, 2025
Malahide (Dublin), Ireland
#ESHERYTHRO2025
CONFERENCE'S LEARNING OBJECTIVES
Upon completion of this CME activity, participants will learn about:
• Increasing our understanding of regulatory mechanisms of erythropoiesis
• Post-transcriptional regulation of erythropoiesis
• Listing the causes of ineffective erythropoiesis and the potential targets for innovative treatments
This meeting will be valuable to you if you are looking for:
• A cutting-edge scientific program – from basic science to clinical and therapeutic applications and perspectives
• Multiple opportunities for scientific interaction with an international faculty of distinguished experts
• An emphasis on critical discussion
The meeting will provide clinicians and scientists with state-of-the-art recommendations regarding patient care and insight in controversies in the field.
PRELIMINARY PROGRAMME
CALL FOR ABSTRACTS
FOR BRIEF ORAL COMMUNICATIONS OR POSTER PRESENTATIONS
The deadline for abstracts submission is December 15th, 2024
THE CONFERENCE'S MAIN SCIENTIFIC TOPICS
• Update on pathophysiology on sickle cell disease,
thalassemia and normal red blood cell
• Iron and erythropoiesis
• Inflammation in sickle cell disease
• Dyserythopoiesis in thalassemia
• Premature aging in sickle cell and thalassemia
• Fetal hemoglobin control
• Novel pharmacologic approaches to sickle cell disease and thalassemia
• Novel genomic approaches to sickle cell and thalassemia
THE PROGRAMME WILL INCLUDE:
Plenary Sessions - Simultaneous Meet the Experts Sessions
Round Table Discussions - Poster Presentations
Short Oral Communications - Ample time for in-depth discussion
MORE INFORMATION HERE